Transient loss of microtubule-associated protein 2 immunoreactivity after moderate brain injury in mice

Jimmy W Huh1, Ramesh Raghupathi, Helmut L Laurer

  • 1Department of Anesthesia and Critical Care, The Children's Hospital of Philadelphia, Pennsylvania, USA.

Journal of Neurotrauma
|November 1, 2003
PubMed

Insights

Microtubule-associated protein 2 (MAP2) levels rapidly decrease after traumatic brain injury (TBI), indicating it

Area of Science:

  • Neuroscience
  • Cell Biology
  • Traumatic Brain Injury Research

Background:

  • Microtubule-associated protein 2 (MAP2) is crucial for microtubule stability and neural plasticity.
  • MAP2 is highly vulnerable to cytoskeletal damage during neuronal injury.

Purpose of the Study:

  • To investigate the acute effects of moderate traumatic brain injury (TBI) on MAP2 expression.
  • To determine if early MAP2 loss predicts neuronal death following TBI.

Main Methods:

  • Adult male C57BL/6 mice underwent controlled cortical impact TBI.
  • Immunohistochemistry was performed on brain sections at various time points post-TBI (5 min to 24 h).

Main Results:

  • Significant MAP2 reduction observed in ipsilateral cortex and hippocampus within 5 min post-TBI.
  • MAP2 loss occurred before substantial neuronal cell death.
  • Partial MAP2 recovery was noted by 90 min and 24 h post-TBI, suggesting intrinsic brain repair capacity.

Conclusions:

  • MAP2 is a sensitive early marker of neuronal damage after TBI.
  • Acute MAP2 loss does not necessarily indicate irreversible neuronal death.
  • The traumatized brain exhibits an intrinsic ability to recover MAP2 expression after moderate TBI.

Related Concept Videos